ArticleAmerican health & drug benefits2015

Evaluating Drug Cost per Response with SGLT2 Inhibitors in Patients with Type 2 Diabetes Mellitus.

Janice M S Lopez et al.PubMed ↗Full text ↗

No numbers read from the abstract.